STING activator c-di-GMP enhances the anti-tumor effects of peptide vaccines in melanoma-bearing mice
Z Wang, E Celis - Cancer Immunology, Immunotherapy, 2015 - Springer
Abstract Therapeutic vaccines to induce anti-tumor CD8 T cells have been used in clinical
trials for advanced melanoma patients, but the clinical response rate and overall survival
time have not improved much. We believe that these dismal outcomes are caused by
trials for advanced melanoma patients, but the clinical response rate and overall survival
time have not improved much. We believe that these dismal outcomes are caused by
For custom peptides, please visit www.pepmic.com. Our peptide services including but not limited to:
*Peptide Synthesis: From short peptides to long peptides, linear peptides to cyclic peptides.
*Peptide Modifications: Peptide-protein conjugation, D-amino acid peptides, isotope peptides, fluorescent peptides, multiple antigen peptides, multiple disulfide bridge peptides, phosphopeptides etc.
*Catalog Peptides: ACE Inhibitors, Amyloids & Related Peptides, Antimicrobial Peptides, Apelin Peptides, Myelin Oligodendrocyte Glycoprotein (MOG) Peptides, TAT Proteins etc.
*Peptide Salt: TFA, Desalt, Acetate, HCl.
*Peptide Purity: From crude to >99.5%.
*Production Capacity: From mg to kg, with a capacity of synthesizing 15,000 peptides/month.
*Peptide Library Synthesis: Alanine Scan, Overlapping, Positional Scan, T-cell Truncated, Scrambled ect.
Quick Links:
Contact Information:
Eva He
eva@pepmic.com
Pepmic Co., Ltdeva@pepmic.com
www.pepmic.com
没有评论:
发表评论